Prolotherapy.
Dextrose-based stimulation of ligament and tendon healing.
A series of small injections of dextrose solution into damaged ligaments and tendons to stimulate a localized healing response — a low-cost, evidence-supported option for select tendinopathies and joint laxity.
A different mechanism: induced inflammation drives repair.
Prolotherapy injects a hypertonic dextrose solution into the enthesis — where ligament or tendon meets bone — producing a localized inflammatory response that recruits fibroblasts and growth factors to reorganize and strengthen the tissue. Unlike PRP and BMAC, no blood draw or marrow harvest is required. It is the lowest-cost option in the regenerative menu.
Ultrasound or palpation-guided injection.
The target ligament or tendon enthesis is identified by palpation or ultrasound. The skin is cleansed and a small volume of dextrose solution is injected at the target site, sometimes at multiple adjacent points to cover the full enthesis. Total appointment time is twenty to forty minutes. No sedation. No down time.
For select chronic tendinopathies and ligamentous laxity.
The strongest data is for chronic lateral epicondylitis, Achilles tendinopathy, plantar fasciitis, knee ligament laxity, and certain sacroiliac and finger joint laxity patterns. Like other regenerative interventions, prolotherapy is not appropriate for acute complete ruptures or for advanced bone-on-bone arthritis.
Soreness expected. Multiple sessions are the norm.
Mild soreness at the injection site for one to three days is expected and part of the mechanism. We avoid anti-inflammatory medication for one to two weeks. Effects build over several weeks. A typical course is three to six monthly sessions, with reassessment at each visit. We measure pain, function, and ultrasound appearance over the series.
Stop accepting the downtime.
A low-cost, evidence-supported option for the right patient. Schedule a consultation at any Triumph location.